First-line treatment with a Keytruda combo had an overall survival of 17.6 months in some with recurrent/metastatic head and ...

Complementary nature of these two immunotherapies leads to excellent 17.6-month median Overall Survival in head and neck ...

Adding perioperative pembrolizumab to standard care can improve EFS in locally advanced head and neck cancer, data suggest.

Low-dose computed tomography is more sensitive than chest radiography in detecting lung metastases or second primary lung cancer in patients with HNSCC.

FDA meeting requested following Phase IIb trial showing median overall survival of 17.6 months without chemotherapy Immutep ...

Immutep believes its LAG-3 candidate eftilagimod alpha may have a path to approval in first-line head and neck cancer after ...

Immutep said a treatment it is developing showed strong results in overall survival among head and neck cancer patients. The Australian cancer-treatment company said Monday the median rate for overall ...

Investors are sending this ASX All Ords share flying on Monday. But why? The post Guess which ASX All Ords share just ...

In a first-of-its-kind surgery, a team led by a University of Maryland Medical Center (UMMC) neurosurgeon has successfully ...

Karla Flores had a tumor strangling her spinal cord near the base of her skull. Doctors weighed whether they should attempt a ...

From puberty onwards, it is important to check for any changes in the testicles regularly. It is usually possible to cure testicular cancer. But it is easier to treat when it is diagnosed early.

Even a little exercise goes a long way for brain protection.